Positive prostate-specific antigen (PSA) results in semen-free samples

Journal of the Canadian Society of Forensic Science

Volumn 37, Issue 4, 2004, Pages 197-206

  Denison, S J ^a,b   Lopes, E M ^b,c   D'Costa, L ^b   Newman, J C ^b  

^a Maxxam Analytics   (Canada)

^b Ministry of Community Safety and Correctional Services Centre of Forensic Sciences   (Canada)

^c Tm Bioscience Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; ARTICLE; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FORENSIC IDENTIFICATION; HUMAN; HUMAN CELL; MALE; OUTCOMES RESEARCH; RAPE; SAMPLING; SEMEN ANALYSIS; SEMINAL PLASMA; SEXUAL CRIME; VALIDATION PROCESS; VASECTOMY;

EID: 14644437017     PISSN: 00085030     EISSN: None     Source Type: Journal    
DOI: 10.1080/00085030.2004.10757576     Document Type: Article

References (32)

1. Hochmeister M.N., Budowle B., Rudin O., Gehrig C., Borer U., Thali M., and Dirnhofer R., Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid. J. Forensic Sci. 1999; 44:1057–1060.
2. Simich J.P., Morris S.L., Klick R.L., and Rittenhouse-Diakun, K., Validation of the use of a commercially available kit for the identification of prostate specific antigen (PSA) in semen stains. J. Forensic Sci. 1999; 44:1229–1231.
3. Willot G.M., Frequency of azoospermia. Forensic Sci. Int. 1982; 20:9–10.
4. Engelmann U.H., Schramek, P., Tomamichel, G., Deindl, F., and Senge, T.H., Vasectomy reversal in central Europe:Results of a questionnaire of urologists in Austria, Germany and Switzerland. J. Urol. 1989; 143:64–67.
5. Picard A., News article referencing the Canadian Institute for Health Information. In:The Globe and Mail, Metro Edition. April 9, 2004; pg Al3.
6. Hara M., Koyanagi Y., Inoue T., and Fukuyama T., Some physico-chemical characteristics of gamma-seminoprotein:An antigenic component specific for human seminal plasma. Jap. J. of Leg. Med. 1971; 25:322–324.
7. Li T.S., and Beling C.G., Isolation and characterization of two specific antigens of human seminal plasma. Fertil. Steril. 1973; 24:134–144.
8. Sensabaugh G.F., Isolation and characterization of a semen-specific protein from human seminal plasma:A potential new marker for semen identification. J. Forensic Sci. 1978; 23:106–115.
9. Wang M.C., Valenzuela L.A., Murphy G.P., and Chu T.M., Purification of a human prostate specific antigen. Invest. Urol. 1979; 17:159–163.
10. Johnson E.D., and Kotowski T.M., Detection of prostate specific antigen by ELISA. J. Forensic Sci. 1993; 38:250–258.
11. Graves H.C., Sensabaugh G.F., and Blake E.T., Postcoital detection of a male-specific semen protein. Application to the investigation of rape. N. Engl. J. Med. 1985; 312:338–343.
12. Poyntz F.M., and Martin P.D., Comparison of p30 and acid phosphatase levels in postcoital vaginal swabs from donor and casework studies. Forensic Sci. Int. 1984; 24:17–25.
13. Baechtel F.S., Immunological methods for seminal fluid identification. In:Proceedings of a Forensic Science Symposium on the analysis of sexual assault evidence. Washington D.C., FBI Laboratory, 1983; 83–89.
14. Stubbings N.A., and Newall P.J., An evaluation of gamma-glutamyl transpeptidase (GGT) and p30 determinations for the identification of semen on postcoital vaginal swabs. J. Forensic Sci. 1985; 30:604–614.
15. Kamenev L., Leclercq M., and Francois-Gerard C. An enzyme immunoassay for prostate-specific p30 antigen detection in the postcoital vaginal tract. J. Forensic Sci. 1989; 29:233–241.
16. Stowell L.I,. Sharman L.E., and Hamel K., An enzyme-linked immunosorbent assay (ELISA) for prostate specific antigen. Forensic Sci. Int. 1991; 50:125–138.
17. Oesterling J.E., Prostate specific antigen:A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol. 1991; 145:907–923.
18. Irani J., Millet C., Levillain P., Dore B., Begon F., and Aubert J., Serum-to-urinary prostate specific antigen ratio:It's impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10ng/mL. J. Urol. 1997; 157:185–188.
19. Yu H., and Diamandis E.P., Prostate-specific antigen in milk of lactating women. Clin. Chem. 1995; 41:54–58.
20. Diamandis E.P., and Yu H., Nonprostatic sources of prostate-specific antigen. Urol. Clin. North Am. 1997; 24:275–282.
21. Yu H., and Berkel H., Prostate-specific antigen (PSA) in women. J. La. State Med. Soc. 1999; 151:209–213.
22. Yu H., and Diamandis E.P., Prostate-specific antigen immunoreactivity in amniotic fluid. Clin. Chem. 1995; 41:204–210.
23. Kind S.S., The Acid Phosphatase Test. In:Curry, A.S., Editors, Methods of Forensic Science, Vol. 3. New York:Interscience., 1964; 267–288.
24. Munsell Color Company Inc. Munsell Book of Color. Baltimore, MD. 1966.
25. Wraxall B., and De Haan J.R., The Use Of p30 Antiserum In Sexual Assault Cases. Presented at:The Joint Canadian Society of Forensic Science/Northwest Association of Forensic Scientists Meeting, 1983.
26. Seratec® PSA Semiquant membrane kit. Technical information sheet. Gesellschaft für Biotechnologie, Germany, 1999.
27. Fernando S.A., and Wilson G.S., Studies of the ‘hook’ effect in the one-step sandwich immunoassay. J. Immunol. Methods. 1992; 151:47–66.
28. Zarghami N., Grass L., Sauter E.R., and Diamandis E.P., Prostate-specific antigen in serum during the menstrual cycle. Clin. Chem. 1997; 43:1862–1867.
29. Colvard D.S., Eriksen E.F., Keeting P.E., Wilson, E.M., Lubahn, D.B., French, F.S., Riggs, B.L., and Spelsberg, T.C., Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 1989; 86:854–857.
30. Stornati M., Rubino S., Spinetti A., Parrini D., Luisi S., Casarosa E., Petraglia F., and Genazzani A.R., Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women. Gynecol Endocrinol. 1999; 13:15–25.
31. Weinstein R.E., Lobocki C.A., Gravett S., Hum H., Negrich R., Herbst J., Greenberg D., and Pieper D.R., Decreased adrenal sex steroid levels in the absence of glucocorticoid suppression in postmenopausal asthmatic women. J Allergy Clin Immunol. 1996; 97:1–8.
32. Kearsey J., Louie H., and Poon H., Validation study of the “Onestep ABACard® PSA test” kit for RCMP casework. Can. Soc. Forensic Sci. J. 2001; 34:63–72.